title: Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia.
abstract: BACKGROUND
  Weight gain is a common consequence of antipsychotic drug treatment and can lead to further morbidity.
  
  
  OBJECTIVE
  To assess the effects of antipsychotic drug therapy on abdominal fat deposition, on insulin and leptin secretion, and on circulating glucose and lipids.
  
  
  METHODS
  Abdominal body fat was determined by magnetic resonance imaging in a group of previously untreated patients with schizophrenia, before and after 10 weeks' antipsychotic drug treatment. Body mass and blood concentrations of glucose, insulin, leptin and lipids were also measured.
  
  
  RESULTS
  Significant increases in both subcutaneous and intra-abdominal fat were identified after antipsychotic drug treatment. A three-fold increase in leptin secretion as well as significant increases in levels of circulating lipids and non-fasting glucose were also identified.
  
  
  CONCLUSIONS
  Patients first receiving antipsychotic drugs experience substantial deposition of both subcutaneous and intra-abdominal fat, reflecting a loss of the normal inhibitory control of leptin on body mass. Along with fat deposition, the increase in levels of fasting lipids and in non-fasting glucose may provide early signs of drug-induced progression towards the metabolic syndrome.
authors.affiliation: Department of Psychiatry Nanjing Brain Hospital and Nanjing Medical University, Nanjing, China.
authors.forename: Zhi-Jun
authors.initials: ZJ
authors.lastname: Zhang
authors.forename: Zhi-Jian
authors.initials: ZJ
authors.lastname: Yao
authors.forename: Wen
authors.initials: W
authors.lastname: Liu
authors.forename: Qun
authors.initials: Q
authors.lastname: Fang
authors.forename: Gavin P
authors.initials: GP
authors.lastname: Reynolds
mesh_terms: D000005:Abdomen / Q000473:pathology; D000273:Adipose Tissue / Q000187:drug effects* / Q000473:pathology; D000328:Adult; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D001824:Body Constitution; D005260:Female; D006801:Humans; D007328:Insulin / Q000097:blood*; D020738:Leptin / Q000097:blood*; D008279:Magnetic Resonance Imaging; D008297:Male; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D012737:Sex Factors; D016896:Treatment Outcome; D015430:Weight Gain / Q000187:drug effects
chemical_list: D014150:Antipsychotic Agents; D001786:Blood Glucose; D007328:Insulin; D020738:Leptin